Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder
Clinical trial NCT01467713 · TERMINATED
Trial details
- NCT number
- NCT01467713
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2015-03-01
- Enrollment
- 642
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.